• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过纳入实验室指标来增强对非瓣膜性心房颤动个体的急性缺血性卒中风险的评估。

Enhancing the evaluation of acute ischemic stroke risk in individuals with non-valvular atrial fibrillation by including laboratory indicators.

机构信息

Department of Cardiology, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, 230001, Anhui, China.

出版信息

Sci Rep. 2024 Mar 21;14(1):6844. doi: 10.1038/s41598-024-57497-x.

DOI:10.1038/s41598-024-57497-x
PMID:38514850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10958006/
Abstract

To investigate the clinical significance of the CHADS-VASc-60 score, lipoprotein (a) [Lp(a)], red blood cell distribution width (RDW), and their combined effect in patients with non-valvular atrial fibrillation (NVAF) who experience acute ischemic stroke (AIS). This retrospective analysis was conducted on the clinical data of hospitalized patients with NVAF at the Third Affiliated Hospital of Anhui Medical University between April 1, 2020, and April 1, 2023. Based on the diagnosis of acute ischemic stroke (AIS), the patients were divided into two groups: the AIS group (150 cases of NVAF patients with comorbid AIS) and the non-AIS group (163 cases of NVAF patients without AIS). We performed CHADS-VASc-60 scoring for all patients and collected their laboratory indicators and echocardiographic indicators during hospitalization. The study comprised 313 individuals with NVAF in total. There is a statistically significant difference (P < 0.05) in the comparison of CHADS-VASc-60 score (5.68 ± 1.12 vs. 3.67 ± 1.47), Lp(a) [23.98 (13.28, 42.22) vs. 14.32 (7.96, 21.91)] and RDW (13.67 ± 1.25 vs. 12.94 ± 0.76) between NVAF patients with and without concomitant AIS. The results of the Spearman correlation analysis demonstrate a positive association between Lp(a) and RDW levels and both the CHADS-VASc score and the CHADS-VASc-60 score in patients with NVAF. Multivariate logistic regression analysis revealed that CHADS-VASc-60 score [OR = 6.549, 95% CI: 4.110-10.433, P < 0.05], Lp(a) [OR = 1.023, 95% CI: 1.005-1.041, P < 0.05], and RDW [OR = 1.644, 95% CI: 1.071-2.525, P < 0.05] were independent risk factors for AIS in patients with non-valvular atrial fibrillation (NVAF). The receiver operator characteristic (ROC) curves showed that the area under the curve of CHADS-VASc-60 score, Lp(a), RDW, and CHADS-VASc-60 score combined with Lp(a) and RDW predicted that NVAF patients with AIS were 0.881 [95% CI: 0.804-0.906], 0.685 [95% CI: 0.626-0.744], 0.695 [95% CI: 0.637-0.754], and 0.906 [95% CI: 0.845-0.921], respectively. The CHADS-VASc-60 score, Lp(a), and RDW were significantly increased in NVAF patients with AIS, which were independent risk factors for NVAF patients with AIS. The combination of the three has a high predictive capacity for NVAF patients with AIS.

摘要

目的

探讨 CHADS-VASc-60 评分、脂蛋白(a)[Lp(a)]、红细胞分布宽度(RDW)及其联合作用在伴有急性缺血性脑卒中(AIS)的非瓣膜性心房颤动(NVAF)患者中的临床意义。本回顾性分析纳入了 2020 年 4 月 1 日至 2023 年 4 月 1 日期间在安徽医科大学第三附属医院住院的 NVAF 患者的临床资料。根据急性缺血性脑卒中(AIS)的诊断,将患者分为两组:AIS 组(150 例伴有 AIS 的 NVAF 患者)和非 AIS 组(163 例无 AIS 的 NVAF 患者)。我们对所有患者进行 CHADS-VASc-60 评分,并收集他们住院期间的实验室指标和超声心动图指标。本研究共纳入 313 例 NVAF 患者。NVAF 伴或不伴 AIS 患者的 CHADS-VASc-60 评分(5.68±1.12 与 3.67±1.47)、Lp(a)[23.98(13.28,42.22)与 14.32(7.96,21.91)]和 RDW(13.67±1.25 与 12.94±0.76)比较差异有统计学意义(P<0.05)。Spearman 相关分析结果显示,NVAF 患者的 Lp(a)和 RDW 水平与 CHADS-VASc 评分和 CHADS-VASc-60 评分呈正相关。多变量 logistic 回归分析显示,CHADS-VASc-60 评分[OR=6.549,95%CI:4.110-10.433,P<0.05]、Lp(a)[OR=1.023,95%CI:1.005-1.041,P<0.05]和 RDW[OR=1.644,95%CI:1.071-2.525,P<0.05]是非瓣膜性心房颤动(NVAF)患者发生 AIS 的独立危险因素。受试者工作特征(ROC)曲线显示,CHADS-VASc-60 评分、Lp(a)、RDW 以及 CHADS-VASc-60 评分联合 Lp(a)和 RDW 预测 NVAF 患者发生 AIS 的曲线下面积分别为 0.881[95%CI:0.804-0.906]、0.685[95%CI:0.626-0.744]、0.695[95%CI:0.637-0.754]和 0.906[95%CI:0.845-0.921]。AIS 组 NVAF 患者的 CHADS-VASc-60 评分、Lp(a)和 RDW 均显著升高,均为 NVAF 患者发生 AIS 的独立危险因素。三者联合具有较高的预测 AIS 能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46bf/10958006/360c536154e7/41598_2024_57497_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46bf/10958006/beb412ed5b67/41598_2024_57497_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46bf/10958006/360c536154e7/41598_2024_57497_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46bf/10958006/beb412ed5b67/41598_2024_57497_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46bf/10958006/360c536154e7/41598_2024_57497_Fig2_HTML.jpg

相似文献

1
Enhancing the evaluation of acute ischemic stroke risk in individuals with non-valvular atrial fibrillation by including laboratory indicators.通过纳入实验室指标来增强对非瓣膜性心房颤动个体的急性缺血性卒中风险的评估。
Sci Rep. 2024 Mar 21;14(1):6844. doi: 10.1038/s41598-024-57497-x.
2
Significance of CHADS-VAS on the severity and hemorrhagic transformation in patients with non-valvular atrial fibrillation-induced acute ischemic stroke.非瓣膜性心房颤动引起的急性缺血性脑卒中患者 CHADS-VAS 评分与严重程度和出血性转化的关系。
Intern Emerg Med. 2021 Aug;16(5):1155-1163. doi: 10.1007/s11739-020-02558-y. Epub 2021 Jan 1.
3
Development and Validation of a New Nomogram Model for Predicting Acute Ischemic Stroke in Elderly Patients with Non-Valvular Atrial Fibrillation: A Single-Center Cross-Sectional Study.开发和验证一种新的列线图模型预测非瓣膜性心房颤动老年患者急性缺血性脑卒中:一项单中心横断面研究。
Clin Interv Aging. 2024 Jan 10;19:67-79. doi: 10.2147/CIA.S437065. eCollection 2024.
4
Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHADS-VASc scores: a cross-sectional study.脂蛋白(a)对低 CHADS-VASc 评分的非瓣膜性心房颤动患者左心房血栓或自发性回声对比的预测价值:一项横断面研究。
Lipids Health Dis. 2024 Jan 22;23(1):22. doi: 10.1186/s12944-023-01990-1.
5
Relation of red blood cell distribution width with CHADS and CHADS-VASc score in Chinese patients with non-valvular atrial fibrillation.中国非瓣膜性心房颤动患者红细胞分布宽度与CHADS及CHADS-VASc评分的关系
Int J Cardiol. 2017 Feb 1;228:861-864. doi: 10.1016/j.ijcard.2016.11.255. Epub 2016 Nov 14.
6
Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.CHA2DS2-VASc评分低的非瓣膜性心房颤动患者发生血栓栓塞的危险因素。
Medicine (Baltimore). 2019 Feb;98(8):e14549. doi: 10.1097/MD.0000000000014549.
7
Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis.CHA2DS2-VASc 评分在预测伴有或不伴有心房颤动的缺血性卒中患者中的作用:系统评价和荟萃分析。
Eur J Prev Cardiol. 2022 Mar 30;29(4):625-631. doi: 10.1093/eurjpc/zwab018.
8
Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHADS-VASc score.低CHADS-VASc评分的非瓣膜性心房颤动患者左心房血栓或自发显影的危险因素。
J Thromb Thrombolysis. 2022 Feb;53(2):523-531. doi: 10.1007/s11239-021-02554-9. Epub 2021 Sep 2.
9
Relation of red cell distribution width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者红细胞分布宽度与CHA2DS2-VASc评分的关系
Clin Appl Thromb Hemost. 2014 Oct;20(7):687-92. doi: 10.1177/1076029613478157. Epub 2013 Feb 21.
10
External validation and comparison of CHADS-VASc-RAF and CHADS-VASc-LAF scores for predicting left atrial thrombus and spontaneous echo contrast in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者左心房血栓和自发性回声对比中 CHADS-VASc-RAF 和 CHADS-VASc-LAF 评分的外部验证和比较。
J Interv Card Electrophysiol. 2022 Nov;65(2):535-542. doi: 10.1007/s10840-022-01285-y. Epub 2022 Jul 13.

本文引用的文献

1
Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHADS-VASc scores: a cross-sectional study.脂蛋白(a)对低 CHADS-VASc 评分的非瓣膜性心房颤动患者左心房血栓或自发性回声对比的预测价值:一项横断面研究。
Lipids Health Dis. 2024 Jan 22;23(1):22. doi: 10.1186/s12944-023-01990-1.
2
Development and Validation of a New Nomogram Model for Predicting Acute Ischemic Stroke in Elderly Patients with Non-Valvular Atrial Fibrillation: A Single-Center Cross-Sectional Study.开发和验证一种新的列线图模型预测非瓣膜性心房颤动老年患者急性缺血性脑卒中:一项单中心横断面研究。
Clin Interv Aging. 2024 Jan 10;19:67-79. doi: 10.2147/CIA.S437065. eCollection 2024.
3
Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width in Patients with Atrial Fibrillation and Rheumatic Valve Disease.
中性粒细胞与淋巴细胞比值及红细胞分布宽度在心房颤动合并风湿性心脏瓣膜病患者中的变化
Curr Vasc Pharmacol. 2023;21(6):367-377. doi: 10.2174/1570161121666230726123444.
4
Value of ATRIA stroke risk score in predicting atrial high-rate episodes: A comparison of six different risk scores.ATRIA 卒中风险评分在预测心房高频事件中的价值:六种不同风险评分的比较。
Pacing Clin Electrophysiol. 2023 Aug;46(8):978-985. doi: 10.1111/pace.14749. Epub 2023 Jun 7.
5
Assessment of the efficacy of the electrocardiographic P-wave peak time in predicting atrial high rate episode in patients with cardiac implantable electronic devices.评估心电图P波峰时间在预测心脏植入式电子设备患者房性高率发作中的有效性。
J Electrocardiol. 2023 Sep-Oct;80:40-44. doi: 10.1016/j.jelectrocard.2023.05.001. Epub 2023 May 6.
6
Association between lipoprotein(a) and thromboembolism in patients with non-valvular atrial fibrillation: a cross-sectional study.脂蛋白(a)与非瓣膜性心房颤动患者血栓栓塞的关系:一项横断面研究。
Lipids Health Dis. 2022 Aug 25;21(1):78. doi: 10.1186/s12944-022-01682-2.
7
Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.脂蛋白(a)水平升高与心房颤动风险:一项观察性和孟德尔随机化研究。
J Am Coll Cardiol. 2022 Apr 26;79(16):1579-1590. doi: 10.1016/j.jacc.2022.02.018.
8
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.亚太心律学会(APHRS)2017年房颤卒中预防共识指南2021年重点更新。
J Arrhythm. 2021 Nov 13;37(6):1389-1426. doi: 10.1002/joa3.12652. eCollection 2021 Dec.
9
PCSK9 Inhibition and Oxidized Phospholipids.前蛋白转化酶枯草溶菌素9抑制与氧化磷脂
J Am Coll Cardiol. 2021 Sep 21;78(12):1288-1289. doi: 10.1016/j.jacc.2021.07.031.
10
A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中评估生物标志物综述
Front Cardiovasc Med. 2021 Jul 1;8:682538. doi: 10.3389/fcvm.2021.682538. eCollection 2021.